Trial of IW-1973, A Stimulator of Soluble Guanylate Cyclase (sGC) in Patients With Stable Type 2 Diabetes and Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

February 28, 2017

Primary Completion Date

August 3, 2017

Study Completion Date

August 3, 2017

Conditions
Diabetes Mellitus, Type 2Hypertension
Interventions
DRUG

IW-1973

Oral Tablet

DRUG

Placebo

Oral Tablet

Trial Locations (1)

91911

ProSciento, Inc., Chula Vista

Sponsors
All Listed Sponsors
lead

Cyclerion Therapeutics

INDUSTRY